youtube_live
Q3 2026 earnings • released • EPS beat +2.32% • Revenue miss -0.16%
See resultschevron_right
ALC:NYSE
Alcon AG
$74.12
arrow_upward
+3.20%(+2.30) 1D
Nov 13, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$72.97
High
$74.18
Low
$72.58
Mkt. cap
31.48B
Avg. vol.
2.09M
Volume
0.00
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$72.97
High
$74.18
Low
$72.58
Mkt. cap
31.48B
Avg. vol.
2.09M
Volume
0.00
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Bulls See S&P 500 Hitting 7,900 by Year-End as Earnings and Valuations Improve
Yahoo Finance
·
47 minutes ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Benzinga
·
2 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
StoneX
·
3 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com